Associated Factors With Survivals In Patients Undergoing Orthotopic Heart Transplant Using Retrograde Blood Microcardioplegia.

dc.creatorLavagnoli, Carlos Fernando Ramos
dc.creatorSeverino, Elaine Soraya Barbosa de Oliveira
dc.creatorVilarinho, Karlos Alexandre de Souza
dc.creatorSilveira Filho, Lindemberg da Mota
dc.creatorOliveira, Pedro Paulo Martins de
dc.creatorPetrucci, Orlando
dc.creatorVieira, Reinaldo Wilson
dc.creatorBraile, Domingo Marcolino
dc.date
dc.date2015-11-27T13:29:07Z
dc.date2015-11-27T13:29:07Z
dc.date.accessioned2018-03-29T01:16:33Z
dc.date.available2018-03-29T01:16:33Z
dc.identifierRevista Brasileira De Cirurgia Cardiovascular : órgão Oficial Da Sociedade Brasileira De Cirurgia Cardiovascular. v. 27, n. 3, p. 347-54
dc.identifier1678-9741
dc.identifier
dc.identifierhttp://www.ncbi.nlm.nih.gov/pubmed/23288174
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/200317
dc.identifier23288174
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1300550
dc.descriptionSeveral techniques and cardioplegic solutions have been used for heart preservation during transplant procedures. Unfortunately, there is a lack of ideal method for myocardial preservation in the clinical practice. The use of retrograde cardioplegia provides continuous infusion of cardioplegic solution during the graft implantation. This strategy may provide better initial recovery of the graft. The objective of this study is to describe the experience of a single center where all patients received the same solution for organ preservation and were subjected to continuous retrograde blood microcardioplegia during implantation of the graft and to evaluate factors associated to early and late mortality with this technique. This is a retrospective, observational and descriptive study of a single center. During the study period were performed 35 heart transplants. Fifteen (42.9%) patients were in cardiogenic shock. The probability of survival was 74.8±7.8%, 60.4±11.3% and 15.1±13.4% at 1 year, 5 years and 10 years of follow-up, respectively. The median survival time was 96.6 months. The use of myocardial protection with retrograde cardioplegic solution may reduce the risks associated morbidity due to cold ischemia time during the heart transplant, and we suggest that this benefit may be even greater in cases of cold ischemia time longer ensuring protection to the myocardium.
dc.description27
dc.description347-54
dc.languageeng
dc.languagepor
dc.relationRevista Brasileira De Cirurgia Cardiovascular : órgão Oficial Da Sociedade Brasileira De Cirurgia Cardiovascular
dc.relationRev Bras Cir Cardiovasc
dc.rightsaberto
dc.rights
dc.sourcePubMed
dc.subjectAdult
dc.subjectBrazil
dc.subjectCardioplegic Solutions
dc.subjectEpidemiologic Methods
dc.subjectFemale
dc.subjectHeart
dc.subjectHeart Arrest, Induced
dc.subjectHeart Transplantation
dc.subjectHumans
dc.subjectMale
dc.subjectMiddle Aged
dc.subjectOrgan Preservation
dc.subjectTime Factors
dc.subjectTreatment Outcome
dc.titleAssociated Factors With Survivals In Patients Undergoing Orthotopic Heart Transplant Using Retrograde Blood Microcardioplegia.
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución